{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:20:47Z","timestamp":1767968447142,"version":"3.49.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/mph.0b013e3182352da9","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T21:29:31Z","timestamp":1371158971000},"page":"263-270","source":"Crossref","is-referenced-by-count":6,"title":["RALLE Pilot"],"prefix":"10.1097","volume":"34","author":[{"given":"Ulla M.","family":"Saarinen-Pihkala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katriina","family":"Parto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pekka","family":"Riikonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e4ivi M.","family":"L\u00e4hteenm\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert N.","family":"B\u00e9k\u00e0ssy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Glomstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merja","family":"M\u00f6tt\u00f6nen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"suppl 5","key":"R1-5-20210227","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/annonc\/mdg755","article-title":"Childhood cancer survival in Europe.","volume":"14","author":"Gatta","year":"2003","journal-title":"Ann Oncol"},{"key":"R2-5-20210227","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/sj.leu.2403467","article-title":"Low-dose oral etoposide-based induction regimen for children with acute lymphoblastic leukemia in first bone marrow relapse.","volume":"18","author":"Hijiya","year":"2004","journal-title":"Leukemia"},{"key":"R3-5-20210227","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2141.2005.05572.x","article-title":"Outcome after first relapse in childhood acute lymphoblastic leukemialessons from the United Kingdom R2 trial.","volume":"130","author":"Roy","year":"2005","journal-title":"Br J Haemat"},{"key":"R4-5-20210227","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1200\/JCO.2005.01.1031","article-title":"Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lmphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster group 87.","volume":"23","author":"Einsiedel","year":"2005","journal-title":"J Clin Oncol"},{"key":"R5-5-20210227","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/cncr.20743","article-title":"Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.","volume":"103","author":"Rivera","year":"2005","journal-title":"Cancer"},{"key":"R6-5-20210227","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/pbc.20363","article-title":"Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantationA report from the Kyushu-Yamaguchi Childrens Cancer Study Group.","volume":"45","author":"Matsuzaki","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"R7-5-20210227","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1200\/JCO.2006.07.1225","article-title":"Pathways through relapses and deaths of children with acute lymphoblastic leukemia: role of allogeneic stem-cell transplantation in Nordic data.","volume":"24","author":"Saarinen-Pihkala","year":"2006","journal-title":"J Clin Oncol"},{"key":"R8-5-20210227","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1200\/JCO.2005.04.5856","article-title":"Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and initial bone marrow relapse within 12 months of the completion of primary therapy: childrens Oncology Group study CCG-1941.","volume":"24","author":"Gaynon","year":"2006","journal-title":"J Clin Oncol"},{"key":"R9-5-20210227","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/leu.2008.227","article-title":"Minimal residual disease is an important predictive factor of outcome in children with relapsed high-risk acute lymphoblastic leukemia.","volume":"22","author":"Paganin","year":"2008","journal-title":"Leukemia"},{"key":"R11-5-20210227","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1200\/JCO.2009.22.2950","article-title":"Outcome of patients treated for relapse or refractory acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia consortium study.","volume":"28","author":"Ko","year":"2009","journal-title":"J Clin Oncol"},{"key":"R12-5-20210227","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1200\/JCO.2009.25.1983","article-title":"Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: result of trial ALL-Rez BFM 90.","volume":"28","author":"Tallen","year":"2010","journal-title":"J Clin Oncol"},{"key":"R13-5-20210227","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1200\/JCO.2008.17.6065","article-title":"Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukaemia: the ALL-REZ BFM study group.","volume":"27","author":"Bader","year":"2008","journal-title":"J Clin Oncol"},{"key":"R14-5-20210227","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/pbc.10461","article-title":"Outcome of children with high-risk acute lymphoblastic leukemia: nordic results on an intensive regimen with restricted central nervous system irradiation.","volume":"42","author":"Saarinen-Pihkala","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"R15-5-20210227","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1651-2227.1998.tb00923.x","article-title":"Intensified treatment of acute childhood lymphoblastic leukemia has improved prognosis, especially in non-high risk patients. The Nordic experience of 2648 patients diagnosed between 1981 and 1996.","volume":"87","author":"Gustafsson","year":"1998","journal-title":"Acta Paediatr"},{"key":"R16-5-20210227","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/sj.leu.2401961","article-title":"Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation.","volume":"14","author":"Gustafsson","year":"2000","journal-title":"Leukemia"},{"key":"R17-5-20210227","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/leu.2009.251","article-title":"Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia.","volume":"24","author":"Schmiegelow","year":"2010","journal-title":"Leukemia"},{"key":"R18-5-20210227","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1182\/blood.V96.5.1709","article-title":"Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group study.","volume":"96","author":"Abshire","year":"2000","journal-title":"Blood"},{"key":"R19-5-20210227","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1200\/JCO.2001.19.14.3406","article-title":"No disadvantage in outcome in using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission.","volume":"19","author":"Saarinen-Pihkala","year":"2001","journal-title":"J Clin Oncol"},{"key":"R20-5-20210227","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"R21-5-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and experience.","volume":"35","author":"Peto","year":"1977","journal-title":"Br J Cancer"},{"key":"R22-5-20210227","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1200\/JCO.2008.16.1414","article-title":"Reinduction platform for children with first marrow relapse of acute lymphoblastic leukemia: a Childrens Oncology Group study.","volume":"26","author":"Raetz","year":"2008","journal-title":"J Clin Oncol"},{"key":"R23-5-20210227","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1038\/leu.2008.251","article-title":"Factors influencing survival after relapse from acute lymphoblastic leukemia: a Childrens Oncology Group study.","volume":"22","author":"Nguyen","year":"2008","journal-title":"Leukemia"},{"key":"R24-5-20210227","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0140-6736(01)06355-3","article-title":"Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia.","volume":"358","author":"Eckert","year":"2001","journal-title":"Lancet"},{"key":"R25-5-20210227","first-page":"231","article-title":"Implications of kinetic heterogeneity in clinical oncology.","volume":"12","author":"Norton","year":"1986","journal-title":"Semin Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e3182352da9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:11:35Z","timestamp":1620965495000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201205000-00005"}},"subtitle":["Response-guided Therapy for Marrow Relapse in Acute Lymphoblastic Leukemia in Children"],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3182352da9","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}